Atlas Trials

Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism

Clinical trial NCT00287820 · COMPLETED

Trial details

NCT number
NCT00287820
Sponsor
Nathan Kline Institute for Psychiatric Research
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaDiabetesMetabolic SyndromeHyperglycemia
Start date
2004-02-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.